Zidesamtinib

Zidesamtinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T72953-1mg 1 mg

7 - 10 business days*

161.00€
TGM-T72953-5mg 5 mg

7 - 10 business days*

371.00€
TGM-T72953-10mg 10 mg

7 - 10 business days*

660.00€
TGM-T72953-25mg 25 mg

7 - 10 business days*

1,160.00€
TGM-T72953-50mg 50 mg

7 - 10 business days*

1,571.00€
TGM-T72953-100mg 100 mg

7 - 10 business days*

2,232.00€
 
Description: Zidesamtinib (NVL-520) is an orally active, selective, potent, and... more
Product information "Zidesamtinib"
Description: Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors. Target: ROS Kinase. Smiles: C(C)N1C2=C(CC=3C(C=4C([C@@H](C)OC=5C=C2C=NC5N)=CC(F)=CC4)=NN(C)N3)C=N1. References: Drilon A, et al. NVL-520 is a selective, TRK-sparing, and brain-penetrant inhibitor of ROS1 fusions and secondary resistance mutations. Cancer Discov. 2022 Dec 13,CD-22-0968.
Keywords: NVL-520
Supplier: TargetMol
Supplier-Nr: T72953

Properties

Application: Targets proto-oncogene tyrosine-protein kinase ROS [EC:2.7.10.1] (ROS1)
MW: 419.455 D
Formula: C22H22FN7O

Database Information

CAS : 2739829-00-4| Matching products
KEGG ID : K05088 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Zidesamtinib"
Write a review
or to review a product.
Viewed